CRVS
Corvus Pharmaceuticals, Inc.$12.05+0.46 (+3.92%)Prev Close$11.60·MCap$985.5M·P/E—·Vol747.0K·Yield—
▲
Buys (12M)
1
$83.5K
▼
Sells (12M)
1
$9.78M
◆
Net Activity
Net Seller
$9.70M
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Corvus Pharmaceuticals, Inc. (CRVS) has been dominated by selling, with 1 insider purchase totaling $83.5K and 1 insider sale totaling $9.78M. The most recent insider transaction was by MILLER RICHARD A MD (director, officer: President and CEO), who purchased $83.5K worth of shares on May 20, 2026. Corvus Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $985.5M.
CRVS Insider Trading Activity
CRVS Insider Buying Activity
The following table shows recent insider purchases of Corvus Pharmaceuticals, Inc. (CRVS) stock reported via SEC Form 4 filings.
CRVS Insider Selling Activity
The following table shows recent insider sales of Corvus Pharmaceuticals, Inc. (CRVS) stock reported via SEC Form 4 filings.